Cargando…
Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors
Central nervous system (CNS) malignancies are associated with poor prognosis, as well as exceptional morbidity and mortality, likely as a result of low rates of early diagnosis and limited knowledge of the tumor growth and resistance mechanisms, dissemination, and evolution in the CNS. Monitoring pa...
Autores principales: | Yan, Weiwei, Xu, Tingting, Zhu, Hui, Yu, Jinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986252/ https://www.ncbi.nlm.nih.gov/pubmed/32158224 http://dx.doi.org/10.2147/OTT.S229562 |
Ejemplares similares
-
Liquid biopsy and tumor DNA/RNA detection in the cerebrospinal fluid of patients diagnosed with central nervous system glioma – A review article
por: Borba, Luis A. B., et al.
Publicado: (2023) -
Liquid biopsy for pediatric central nervous system tumors
por: Bonner, Erin R., et al.
Publicado: (2018) -
Tracking Tumor Evolution in Glioma through Liquid Biopsies of Cerebrospinal Fluid
por: Miller, Alexandra M., et al.
Publicado: (2019) -
Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas
por: Bobillo, Sabela, et al.
Publicado: (2020) -
Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas
por: Hickmann, Anne-Katrin, et al.
Publicado: (2019)